Regent Pacific Group (HKSE:00575) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 13, 2026)


HKSE:00575 Regent Pacific Group Ltd HKSE:00575
12 GF Score
Price HK$0.92
GF Value HK$0.56
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Regent Pacific Group Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Regent Pacific Group's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


HKSE:00575 vs ZTS, UTHR: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Regent Pacific Group's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regent Pacific Group Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regent Pacific Group's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Regent Pacific Group's Margin of Safety % (DCF Earnings Based) falls into.


HKSE:00575
12GF Score
Regent Pacific Group Ltd HKSE:00575
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Regent Pacific Group (HKSE:00575) Overvalued in 2026?

Based on GuruFocus' analysis, Regent Pacific Group stock appears to be overvalued. The current stock price of HK$0.92 is trading 64.3% above its estimated GF Value™ of HK$0.56. GuruFocus considers Regent Pacific Group to be Significantly Overvalued.

Key valuation signals for HKSE:00575:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: HK$0.56 vs. price of HK$0.92 (64.3% above fair value)
  • GF Score™: 12/100 with 7 warning signs

No single metric tells the full story. See the HKSE:00575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Regent Pacific Group Business Description

Other Exchanges RPG:Germany
Address 5 Queen\'s Road Central, 8th Floor, Henley Building, Hong Kong, HKG
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.
12GF Score

Get the complete analysis for HKSE:00575

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.92
Price
HK$0.56
GF Value